AIG
JUNO

American International Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

American International Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5
Closed -$900 – 5130
2015
Q2 		$900 Buy
+5
New +$265 ﹤0.01% 4984

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

American International Group's JUNO Position: Q1 2018 in Review

American International Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,435 shares — an estimated $66K sold.

American International Group first reported a position in JUNO in Q4 2014 and held it in 12 quarters. The position peaked at $1.13M in Q3 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • American International Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • American International Group sold 1,435 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $66K.
  • American International Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
  • American International Group's Juno Therapeutics, Inc. position peaked at $1.13M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on American International Group's 13F filing for Q1 2018, filed 7 May 2018.